6505--Radiopharmaceuticals
ID: 36C24126Q0145Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF241-NETWORK CONTRACT OFFICE 01 (36C241)TOGUS, ME, 04330, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/b35fc9587a374c7ca1ddf2d78401583d/view
Timeline
    Description

    The Department of Veterans Affairs, Network Contracting Office 01, intends to award a sole source contract to Pharmalogic LTD for the provision of radiopharmaceuticals to support the Veterans Affairs Medical Center (VAMC) in White River Junction, Vermont. The contractor is required to supply USDA and USP-approved radiopharmaceuticals, including specific products such as Kinevac and TC-99M DTPA, on an as-needed basis, with a commitment to provide 24/7 ordering and delivery services, typically involving two deliveries per day. This procurement is critical for the VAMC's nuclear medicine operations, ensuring timely access to essential medical supplies for patient care. Interested parties capable of fulfilling these requirements must submit their capabilities in writing by December 31, 2025, at 4 PM EST, to Jerry Choinski at jerry.choinski@va.gov.

    Point(s) of Contact
    Jerry ChoinskiContracting Specialist
    (203) 932-5711
    jerry.choinski@va.gov
    Files
    Title
    Posted
    36C24126Q0145.docx
    The Department of Veterans Affairs, NCO 01, intends to award a sole source contract to Pharmalogic LTD for radiopharmaceuticals to support the VAMC White River Junction. This procurement, under FAR 6.302-1, requires the contractor to provide USDA and USP-approved radiopharmaceuticals, including Kinevac, TC-99M DTPA, I-123 Diagnostic Cap, and other specialized items, on an as-needed basis. The contractor must be Nuclear Regulatory Commission licensed and provide 24/7 ordering and delivery services, with a routine of two deliveries per day. Emergency deliveries are subject to an additional fee and have specific timeframes. Authorized VA staff will place orders, and deliveries will be made to the Nuclear Medicine Department. This notice is not a solicitation, but interested parties capable of meeting the requirements must submit their capabilities in writing by December 31, 2025, at 4 PM EST. The government retains discretion to determine if competitive procedures will be used.
    Lifecycle
    Title
    Type
    6505--Radiopharmaceuticals
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--Radiopharmaceuticals
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 01, intends to enter into a sole source procurement with Cardinal Health, Inc. for the provision of radiopharmaceutical products to support the VA Manchester Healthcare System in Manchester, NH. The contractor is required to deliver a range of radiopharmaceuticals, including FDG doses and various isotopes, with specific turnaround times and delivery commitments to meet the healthcare needs of veterans. This procurement is critical for ensuring timely access to essential nuclear medicine and PET radiopharmaceuticals, which are vital for patient care. Interested parties that believe they can fulfill these requirements must submit their capabilities in writing by November 26, 2025, to Jerry Choinski at jerry.choinski@va.gov.
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) (NDC 71258-0022-01)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking sources for the procurement of Pylarify (Piflufolastat F 18 Injection), a radiopharmaceutical injection, to be delivered to VISN 2 Downstate Hospitals. This Sources Sought Notice aims to identify potential large and small businesses, including manufacturers and distributors, capable of providing functionally equivalent products. The procurement is essential for the VA's medical supply needs, particularly in the context of radiopharmaceutical applications in patient care. Interested parties must submit their responses, including firm details and contact information, via email to Aleta Jennette at Aleta.Jennette@va.gov by January 12, 2026, at 10 AM Eastern Time.
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Radiology & Imaging FY2025 Solicitation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a Request for Proposal (RFP) for the procurement of Radiology Imaging Systems and Accessories, under solicitation number 36H79725R0003. This opportunity encompasses a five-year base period with an option for an additional five years, aiming to establish multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts valued at approximately $6.5 billion over ten years, supporting both the VA and the Department of Defense. The solicitation includes detailed requirements for imaging modalities, compliance with DICOM standards, and contractor responsibilities for training and product support, with proposals due by February 3, 2026. Interested vendors should direct inquiries to LaTonya Whiteside at LaTonya.Whiteside@va.gov by December 18, 2025, to ensure clarity in their submissions.
    6525--SEP 2025 Equipment Only Consolidation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Veterans Affairs Medical Center, is seeking proposals for the procurement of a new Cardiovascular Radiographic/Fluoroscopic (R/F) System to replace outdated equipment in its catheterization lab. This system is essential for performing various vascular and interventional procedures, requiring advanced imaging capabilities, including specific gantry dimensions, rotation ranges, and integration with existing VA imaging systems. The procurement emphasizes the importance of enhanced patient care and operational efficiency, with a focus on security and connectivity requirements, including DICOM compliance and encrypted hard drives. Interested vendors should contact Teresa Rogofsky at teresa.rogofsky@va.gov for further details, with proposals due by the specified deadline.
    Teleradiology Services for the Augusta VAMC
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for Teleradiology Services for the Augusta VA Health Care System, specifically seeking Board Certified/Board Eligible Radiologists and Nuclear Medicine Physicians. The contract, under requisition number 36C24726Q0170, aims to provide diagnostic interpretation and reporting services over two ordering periods from April 1, 2026, to March 31, 2028, with an estimated maximum value of $9.5 million. These services are crucial for maintaining high standards of patient care and must comply with American College of Radiology Guidelines, TJC, and VA standards, while ensuring contractors manage qualified personnel and adhere to extensive credentialing and training requirements. Interested parties should contact Matthew Durden at matthew.durden@va.gov or Jason Compton at jason.compton1@va.gov for further details.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.